Antitumor and immunostimulatory activity of a polysaccharide-protein complex from Scolopendra subspinipes mutilans L. Koch in tumor-bearing mice

Food and Chemical Toxicology

Volumn 50, Issue 8, 2012, Pages 2648-2655

  Zhao, Haixia ^a   Li, Ying ^a   Wang, Yuzhong ^b   Zhang, Jing ^b   Ouyang, Xiaoming ^a   Peng, Renxiu ^a   Yang, Jing ^a  

^a WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Antitumor; Immunostimulatory activity; Polysaccharide protein complex; Scolopendra subspinipes mutilans L. Koch

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; ANTINEOPLASTIC AGENT; ARACHIDONIC ACID; CYCLOOXYGENASE 2; CYTOCHROME P450 4A; CYTOKINE; INTERLEUKIN 10; MESSENGER RNA; NATURAL PRODUCT; PROSTAGLANDIN E2; PROTEIN POLYSACCHARIDE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; B LYMPHOCYTE; CANCER INHIBITION; CANCER TRANSPLANTATION; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; FEMALE; IMMUNOMODULATION; IMMUNOSTIMULATION; IN VIVO STUDY; LIVER CELL CARCINOMA; LYMPHOCYTE COUNT; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; SARCOMA; SCOLOPENDRA; SCOLOPENDRA SUBSPINIPES MUTILANS; SURVIVAL TIME; TH1 CELL; TH2 CELL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR IMMUNITY;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CATALYSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; DRUGS, CHINESE HERBAL; INTERLEUKIN-10; LYMPHOCYTE SUBSETS; MICE; NEOPLASMS, EXPERIMENTAL; PLANT EXTRACTS; PLANT PROTEINS; POLYSACCHARIDES; TRANSFORMING GROWTH FACTOR BETA;

MUS; SCOLOPENDRA SUBSPINIPES;

EID: 84862642815     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.05.018     Document Type: Article

References (52)

1. Agarwal A., Agrawal U., Verma S., Mohanty N.K., Saxena S. Serum Th1 and Th2 cytokine balance in patients of superficial transitional cell carcinoma of bladder pre- and post-intravesical combination immunotherapy. Immunopharma. Immunot. 2010, 32:348-356.
2. Alexanian A., Rufanova V.A., Miller B., Flasch A., Roman R.J., Sorokin A. Down-regulation of 20-HETE synthesis and signaling inhibits renal adenocarcinoma cell proliferation and tumor growth. Anticancer Res. 2009, 29:3819-3824.
3. Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 2001, 357:539-545.
4. Cai K.X., Tse L.Y., Leung C., Tam P.K., Xu R., Sham M.H. Suppression of lung tumor growth and metastasis in mice by adenoassociated virus-mediated expression of vasostatin. Clin. Cancer Res. 2008, 14:939-949.
5. Chade D.C., Borra R.C., Nascimento I.P., Villanova F.E., Leite L.C., Andrade E., Srougi M., Ramos K.L., Andrade P.M. Immunomodulatory effects of recombinant BCG expressing pertussis toxin on TNF-alpha and IL-10 in a bladder cancer model. J. Exp. Clin. Cancer Res. 2008, 27:78.
6. Chan J.Y., Chan E., Chan S.W., Sze S.Y., Chan M.F., Tsui S.H., Leung K.Y., Chan R.Y., Chung I.Y. Enhancement of in vitro and in vivo anticancer activities of polysaccharide peptide from Grifola frondosa by chemical modifications. Pharm. Biol. 2011, 49:1114-1120.
7. Chen D., Yao W.J., Zhang X.L., Han X.Q., Qu X.Y., Ka W.B., Sun D.G., Wu X.Z., Wen Z.Y. Effects of Gekko sulfated polysaccharide-protein complex on human hepatoma SMMC-7721 cells: Inhibition of proliferation and migration. J. Ethnopharmacol. 2010, 127:702-708.
8. Chen X., Nie W., Yu G., Li Y., Hu Y., Lu J., Jin L. Antitumor and immunomodulatory activity of polysaccharides from Sargassum fusiforme. Food Chem. Toxicol. 2012, 50:695-700.
9. Cohen E., Quistad G.B. Cytotoxic effects of arthropod venoms on various cultured cells. Toxicon 1998, 36:353-358.
10. Daurkin I., Eruslanov E., Stoffs T., Perrin G.Q., Algood C., Gilbert S.M., Rosser C.J., Su L.M., Vieweg J., Kusmartsev S. Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-lipoxygenase-2 pathway. Cancer Res. 2011, 71:6400-6409.
11. Drake C.G., Antonarakis E.S. Update: immunological strategies for prostate cancer. Curr. Urol. Rep. 2010, 11:202-207.
12. Fujita M., Kohanbash G., Fellows-Mayle W., Hamilton R.L., Komohara Y., Decker S.A., Ohlfest J.R., Okada H. COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells. Cancer Res. 2011, 71:2664-2674.
13. Fujiwara T., Fukushi J., Yamamoto S., Matsumoto Y., Setsu N., Oda Y., Yamada H., Okada S., Watari K., Ono M., Kuwano M., Kamura S., Iida K., Okada Y., Koga M., Iwamoto Y. Macrophage infiltration predicts a poor prognosis for human ewing sarcoma. Am. J. Pathol. 2011, 179:1157-1170.
14. Gan L., Zhang S.H., Yang X.L., Xu H.B. Immunomodulation and antitumor activity by a polysaccharide-protein complex from Lycium barbarum. Int. Immunopharmacol. 2004, 4:563-569.
15. Greene E.R., Huang S., Serhan C.N., Panigrahy D. Regulation of inflammation in cancer by eicosanoids. Prostag. Oth. Lipid. M. 2011, 96:27-36.
16. Guo M., Roman R.J., Fenstermacher J.D., Brown S.L., Falck J.R., Arbab A.S., Edwards P.A., Scicli A.G. 9L gliosarcoma cell proliferation and tumor growth in rats are suppressed by N-hydroxy-N'-(4-butyl-2-methylphenol) formamidine (HET0016), a selective inhibitor of CYP4A. J. Pharmacol. Exp. Ther. 2006, 317:97-108.
17. Haque J.A., McMahan R.S., Campbell J.S., Shimizu-Albergine M., Wilson A.M., Botta D., Bammler T.K., Beyer R.P., Montine T.J., Yeh M.M., Kavanagh T.J., Fausto N. Attenuated progression of diet-induced steatohepatitis in glutathione-deficient mice. Lab. Invest. 2010, 90:1704-1717.
18. Iwami K., Natsume A., Wakabayashi T. Cytokine networks in glioma. Neurosurg. Rev. 2011, 34:253-263.
19. Joyce J.A., Pollard J.W. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 2009, 9:239-252.
20. Korkaya H., Liu S., Wicha M.S. Breast cancer stem cells, cytokine networks, and the tumor microenvironment. J. Clin. Invest. 2011, 121:3804-3809.
21. -ΔΔCT method. Methods 2001, 25:402-408.
22. Lv X., Wan J., Yang J., Cheng H., Li Y., Ao Y., Peng R. Cytochrome P450 omega-hydroxylase inhibition reduces cardiomyocyte apoptosis via activation of ERK1/2 signaling in rat myocardial ischemia-reperfusion. Eur. J. Pharmacol. 2008, 596:118-126.
23. Manjili M.H. Revisiting cancer immunoediting by understanding cancer immune complexity. J. Pathol. 2011, 224:5-9.
24. + T-cell-dependent interleukin-2 production in vitro by murine alveolar macrophages: the role of leukotriene B4. Immunology 1997, 91:369-374.
25. Martel Pelletier J., Lajeunesse D., Reboul P. Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs. Ann. Rheum. Dis. 2003, 62:501-509.
26. Ooi V.E., Liu F. Immunomodulation and anticancer activity of polysaccharide-protein complexes. Curr. Med. Chem. 2000, 7:715-729.
27. Panigrahy D., Kaipainen A., Greene E.R., Huang S. Cytochrome P450-derived eicosanoids: the neglected pathway in cancer. Cancer Metastasis Rev. 2010, 29:723-735.
28. Perez Diez A., Joncker N.T., Choi K., Chan W.F., Anderson C.C., Lantz O., Matzinger P. CD4 cells can be more efficient at tumor rejection than CD8 cells. Blood 2007, 109:5346-5354.
29. Pollard J.W. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 2004, 4:71-78.
30. Qian B., Pollard J. Macrophage diversity enhances tumor progression and metastasis. Cell 2010, 141:39-51.
31. Revathi S., Gupta A.K., Soni L.K., Kavitha S., Wagh R., Kaskhedikar S.G. Rationalization of physicochemical characters of 1,5-diarylpyrazole analogs as dual (COX-2/LOX-5) inhibitors: a QSAR approach. J. Pharm. Biomed. Anal. 2006, 42:283-289.
32. Rogers T.L., Holen I. Tumour macrophages as potential targets of bisphosphonates. J. Transl. Med. 2011, 9:177.
33. Russo V. Metabolism, LXR/LXR ligands, and tumor immune escape. J. Leukocyte Biol. 2011, 90:673-679.
34. Shoeb M., Yadav U.C., Srivastava S.K., Ramana K.V. Inhibition of aldose reductase prevents endotoxin-induced inflammation by regulating the arachidonic acid pathway in murine macrophages. Free Radic. Biol. Med. 2011, 51:1686-1696.
35. Solinas G., Schiarea S., Liguori M., Fabbri M., Pesce S., Zammataro L., Pasqualini F., Nebuloni M., Chiabrando C., Mantovani A., Allavena P. Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility. J. Immunol. 2010, 185:642-652.
36. Sunila E.S., Hamsa T.P., Girija Kuttan Effect of Thuja occidentalis and its polysaccharide on cell-mediated immune responses and cytokine levels of metastatic tumor-bearing animals. Pharm. Biol. 2011, 49:1065-1073.
37. Vasievich E.A., Huang L. The suppressive tumor microenvironment: a challenge in cancer immunotherapy. Mol. Pharm. 2011, 8:635-641.
38. Vivier E., Raulet D.H., Moretta A., Caligiuri M.A., Zitvogel L., Lanier L.L., Yokoyama W.M., Ugolini S., Moretta Innate or adaptive immunity? The example of natural killer cells. Science 2011, 331:44-49.
39. Wang D., Dubois R. Eicosanoids and cancer. Nat. Rev. Cancer 2010, 10:181-193.
40. Wang H., Khor T.O., Saw C.L., Lin W., Wu T., Huang Y., Kong A.N. Role of Nrf2 in suppressing LPS-induced inflammation in mouse peritoneal macrophages by polyunsaturated fatty acids docosahexaenoic acid and eicosapentaenoic acid. Mol. Pharm. 2010, 7:2185-2193.
41. Wang R., Lu M., Zhang J., Chen S.F., Luo X.Y., Qin Y., Chen H.Q. Increased IL-10 mRNA expression in tumor-associated macrophage correlated with late stage of lung cancer. J. Exp. Clin. Canc. Res. 2011, 30:62.
42. Wen Y.J., Barlogie B., Yi Q. Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: evidence for their capacity to lyse autologous primary tumor cells. Blood 2001, 97:1750-1755.
43. Xiong Y., Yang Y., Yang J., Chai H., Li Y., Yang J., Jia Z., Wang Z. Tectoridin, an isoflavone glycoside from the flower of Pueraria lobata, prevents acute ethanol-induced liver steatosis in mice. Toxicology 2010, 276:64-72.
44. Xu X.L., Wang C.M., Geng D., Zhang L., Zhang Lu., Hu B. Effects of Centipede extracts on normal mouse and S180, H22 bearing mouse. Zhong Yao Cai 2010, 33:499-503.
45. Yang, J., Chen, G., Zhou, Q., Liu, Y., Zhu, L.X., Li, Y., Yue, J., Ao, Y., 2010. Preparation and biological properties of polysaccharide-protein complex from Scolopendra subspinipes mutilans L.koch. Chinese Patent, CN200710053587.2.
46. Yu W., Chen L., Yang Y.Q., Falck J.R., Guo A.M., Li Y., Yang J. Cytochrome P450 ω-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer. Cancer Chemother. Pharmacol. 2011, 68:619-629.
47. Zamarron B.F., Chen W. Dual roles of immune cells and their factors in cancer development and progression. Int. J. Biol. Sci. 2011, 7:651-658.
48. Zeytin H., Reali E., Zaharoff D.A., Rogers C.J., Schlom J., Greiner J.W. Targeted delivery of murine interferon-γ using a recombinant fowlpox virus: NK cell recruitment to regional lymph nodes and priming of tumor-specific host immunity. J. Interferon Cytokine Res. 2008, 28:73-87.
49. Zhang C.X., Dai Z.R. Immunomodulatory activities on macrophage of a polysaccharide from Sipunculus nudus L. Food Chem. Toxicol. 2011, 49:2961-2967.
50. Zhang M., Zhu L., Cui S.W., Wang Q., Zhou T., Shen H.S. Fractionation, partial characterization and bioactivity of water-soluble polysaccharides and polysaccharide-protein complexes from Pleurotus geesteranus. Int. J. Biol. Macromol. 2011, 48:5-12.
51. Zhou Y.Q., Han L., Liu Z.Q., Du K.C., Li K.Y. Effect of centipede extract on cervical tumor of mice and its mechanism. Zhong Yao Cai 2011, 34:859-864.
52. Zhu Y., Hu C., Li X., Shao B., Sun H., Zhao H., Li Y. Suppressive effects of aluminum trichloride on the T lymphocyte immune function of rats. Food Chem. Toxicol. 2012, 50:532-535.